Promising new drug targets genetic Parkinson's in early trial
NCT ID NCT06602193
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called BIIB122 in 50 people who have a specific genetic form of Parkinson's disease (LRRK2-PD). The main goal is to check the drug's safety and how it affects certain markers in the blood and urine over 12 weeks. Participants are randomly assigned to receive either the drug or a placebo, and neither they nor the doctors know who gets which.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Cedars-Sinai Department of Neurology
Los Angeles, California, 90048, United States
-
Evergreen Health Laboratory
Kirkland, Washington, 98034, United States
-
Hospital Clinic de Barcelona
Barcelona, Spain
-
Hospital Universitari General de Catalunya
Barcelona, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, Spain
-
Hospital Universitario Donostia
Donostia / San Sebastian, Spain
-
Hospital Universitario Virgen del Rocio
Seville, Spain
-
IDIVAL/University Hospital Marques de Valdecilla
Santander, Spain
-
Ichan School of Medicine at Mount Sinai/Beth Israel Downtown-Movement Disorder Center
New York, New York, 10003, United States
-
Inland Northwest Research
Spokane, Washington, 99202, United States
-
Movement Disorders Institute, Sheba Medical Center
Ramat Gan, Israel
-
Parkinson's Disease and Movement Disorders Center
Boca Raton, Florida, 33486, United States
-
Rabin Medical Center
Petah Tikva, Israel
-
Technische Universität Dresden
Dresden, Germany
-
Tel Aviv Medical Center
Tel Aviv, Israel
-
Universitary Hospital La Princesa
Madrid, Spain
-
University Hospital Tübingen
Tübingen, Germany
-
University of California San Francisco
San Francisco, California, 94158, United States
-
University of Lübeck
Lübeck, Germany